These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6345743)

  • 1. Normalization of hematocrit in a uremic patient receiving hemodialysis: role of erythropoietin.
    Chandra M; Garcia JF; Miller ME; Waldbaum RS; Bluestone PA; McVicar M
    J Pediatr; 1983 Jul; 103(1):80-3. PubMed ID: 6345743
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma erythropoietic activity in patients on chronic dialysis with or without kidneys.
    Gral T; Schroth P; Maxwell MH
    Trans Am Soc Artif Intern Organs; 1972; 18(0):291-4, 299. PubMed ID: 4679881
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure.
    McGonigle RJ; Husserl F; Wallin JD; Fisher JW
    Kidney Int; 1984 Feb; 25(2):430-6. PubMed ID: 6727138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma erythropoietin and hematocrit under the influence of chronic hemodialysis treatment (author's transl)].
    Schulz E; Mödder B; Rath K
    Klin Wochenschr; 1977 Jan; 55(2):65-9. PubMed ID: 834018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
    McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
    J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of erythropoiesis following renal transplantation.
    Besarab A; Caro J; Jarrell BE; Francos G; Erslev AJ
    Kidney Int; 1987 Oct; 32(4):526-36. PubMed ID: 3323595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reticulocyte response after immediate withdrawal of recombinant human erythropoietin in chronic hemodialysis patients].
    Caramelo C; Soto C; Neira F; López MD; Jiménez S; Albalate M; de Oña R; Llamas P; Deudero JJ
    Nefrologia; 2004; 24(4):351-6. PubMed ID: 15455495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of erythroid inhibiting factors (EIF) in patients with anemia of chronic renal failure.
    Radtke HW; Rege AB; LaMarche M; Fisher JW
    Proc Clin Dial Transplant Forum; 1979; 9():179-83. PubMed ID: 552040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin inhibitor in plasma from patients with chronic renal failure.
    Moriyama Y; Saito H; Kinoshita Y
    Haematologia (Budap); 1970; 4(1):15-20. PubMed ID: 5522355
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erythropoiesis inhibitor in the blood plasma of children with choronic renal insufficiency].
    Gudim VI; Sigalla P; Ivanova VS; Egart W
    Urol Nefrol (Mosk); 1978; (4):40-3. PubMed ID: 684979
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of erythropoiesis in uremic patients on CAPD.
    Lamperi S; Carozzi S; Icardi A
    Int J Artif Organs; 1983 Jul; 6(4):191-4. PubMed ID: 6629524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism and site of action of erythropoietic inhibiting factor in uremia.
    Moriyama Y
    Isr J Med Sci; 1971; 7(7):1012-5. PubMed ID: 5107152
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients.
    Chandra M; Miller ME; Garcia JF; Mossey RT; McVicar M
    Nephron; 1985; 39(1):26-9. PubMed ID: 3969187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis: the role of erythropoietin.
    Zappacosta AR; Caro J; Erslev A
    Am J Med; 1982 Jan; 72(1):53-7. PubMed ID: 7058823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemoglobin concentration and serum erythropoietin in renal dialysis and transplant patients.
    Summerfield GP; Gyde OH; Forbes AM; Goldsmith HJ; Bellingham AJ
    Scand J Haematol; 1983 Apr; 30(4):389-400. PubMed ID: 6344194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia of chronic renal failure: studies of marrow regulation in the uremic sheep.
    Eschbach JW; Adamson JW; Anderson RG; Dennis MB
    Trans Am Soc Artif Intern Organs; 1972; 18(0):295-300. PubMed ID: 4681673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of erythropoiesis in uremic patients during conservative therapy and in the course of prolonged hemodialysis (using Fe59)].
    Lamperi S; Sitia L; Bandiani G; Muttini P
    Minerva Nefrol; 1970; 17(3):94-9. PubMed ID: 5515034
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of body iron stores on the serum erythropoietin concentration in hemodialyzed patients.
    Teruel JL; Marcen R; Navarro JF; Villafruela JJ; Fernandez Lucas M; Rivera M; Ortuño J
    Am J Nephrol; 1994; 14(2):95-8. PubMed ID: 8080013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.